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Ca21 transport by cardiac sarcoplasmic reticulum is
tightly coupled with the enzymatic activity of Ca21-de-
pendent ATPase, which forms and decomposes an inter-
mediate phosphoenzyme. Heart sarcoplasmic reticulum
Ca21 pump is regulated by cAMP-dependent protein ki-
nase (PKA) phospholamban phosphorylation, which re-
sults in a stimulation of the initial rates of Ca21 trans-
port and Ca21 ATPase activity. In the present studies we
found that acylphosphatase from heart muscle, used at
concentrations within the physiological range, actively
hydrolyzes the phosphoenzyme of cardiac sarcoplasmic
reticulum Ca21 pump, with an apparent Km on the order
of 1027 M, suggesting an high affinity of the enzyme for
this special substrate. In unphosphorylated vesicles
acylphosphatase enhanced the rate of ATP hydrolysis
and Ca21 uptake with a concomitant significant de-
crease in apparent Km for Ca
21 and ATP. In vesicles
whose phospholamban was PKA-phosphorylated,
acylphosphatase also stimulated the rate of Ca21 uptake
and ATP hydrolysis but to a lesser extent, and the Km
values for Ca21 and ATP were not significantly different
with respect to those found in the absence of acylphos-
phatase. These findings suggest that acylphosphatase,
owing to its hydrolytic effect, accelerates the turnover
of the phosphoenzyme intermediate with the conse-
quence of an enhanced activity of Ca21 pump. It is
known that phosphorylation of phospholamban results
in an increase of the rate at which the phosphoenzyme is
decomposed. Thus, as discussed, a competition between
phospholamban and acylphosphatase effect on the phos-
phoenzyme might be proposed to explain why the stim-
ulation induced by this enzyme is less marked in PKA-
phosphorylated than in unphosphorylated heart
vesicles.
Active Ca21 transport across the membranes of sarcoplasmic
reticulum (SR)1 plays a central role in the excitation-contrac-
tion coupling of cardiac muscle. More specifically, this process,
in concert with the activities of two sarcolemmal systems,
namely the Ca21-ATPase and the Na1/Ca21 exchanger (1), is
essential to promote muscle relaxation by rapidly removing
Ca21 from the cytosol (2, 3). As well as in skeletal muscle, the
energy-dependent calcium transport into cardiac SR depends
on the activity of a Ca21-dependent ATPase (EC 3.6.1.3, ATP
phosphohydrolase), which functions as a Ca21 pump, transduc-
ing chemical energy of ATP into osmotic work, consisting in a
gradient of calcium ions across the SR membrane. In fact, Ca21
translocations are tightly coupled with ATP hydrolysis, which
is accomplished by SR Ca21-ATPase through a complex series
of reactions involving the formation and the decomposition of a
phosphoenzyme intermediate (3). As it occurs for other trans-
port ATPase, the phosphoenzyme (EP) of SR Ca21-ATPase was
recognized as an acylphosphate, since phosphorylation takes
place at a carboxyl group of an aspartic acid residue (4, 5). A
distinctive feature of cardiac SR Ca21-ATPase is its regulation
by a specific membrane protein, named phospholamban, whose
phosphorylation by a cAMP- or a Ca21/calmodulin-dependent
protein kinase leads to an increase in the rate of active Ca21
transport (6).
Acylphosphatase (EC 3.6.1.7), a widespread enzyme that is
well represented in skeletal and heart muscle (7), catalyzes the
hydrolysis of the carboxylphosphate bond of acylphosphates
such as 3-phosphoglyceroyl phosphate (8), carbamoyl phos-
phate (9), and succinoyl phosphate (10). For several years we
have been investigating structural and functional properties of
acylphosphatase purified from muscle tissue of various animal
species. More recently we have found that this enzyme, a cy-
tosolic highly basic protein (its pI is approximately 11), in
addition to the above mentioned low molecular weight soluble
substrates, can hydrolyze the acylphosphorylated intermedi-
ates involved in the action mechanism of some transport
ATPases, notably those of erythrocyte membrane (11) and of
heart sarcolemma Ca21-ATPase (12).
In the present paper we report the results of studies that we
conducted to evaluate whether a similar effect of acylphos-
phatase on the EP intermediate of heart SR Ca21-ATPase
resulted in modified functional properties of this important
calcium pump. Possible changes in acylphosphatase effects
upon phospholamban phosphorylation were also investigated.
MATERIALS AND METHODS
Cyclic AMP-dependent protein kinase from bovine heart, 39,59-cyclic
AMP, K1-oxalate, and Tris-ATP were from Sigma Chemie, Milano,
Italy. [g-32P]ATP (3000 Ci/mmol) and 45CaCl2 (29.77 mCi/mg) were
purchased from NEN DuPont (Brussels, Belgium). Nitrocellulose filters
(0.45 mm) were obtained from Sartorius (Firenze, Italy). All other com-
pounds were of analytical grade.
Acylphosphatase was purified to homogeneity from bovine heart
according to Ramponi et al. (13) for the extraction and according to
Stefani et al. (14) for the other steps. The enzyme, isolated as a pure
product, had a specific activity of 3650 units/mg of protein using benzoyl
phosphate as substrate (15). Benzoyl phosphate was synthesized as per
Camici et al. (16). Cardiac sarcoplasmic reticulum vesicle (SRV) protein
content was assayed by the biuret method of Beisenherz et al. (17) using
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bovine serum albumin as a standard.
Preparation of Cardiac SRVs—All operations were carried out at
4 °C. Cardiac SRVs were isolated from trimmed calf ventricles accord-
ing to Jones et al. (18) except that the Ca21-oxalate loading step was
omitted. The final vesicles were stored frozen at 280 °C in 2 mM Hepes,
pH 7, 0.3 M KCl, 0.3 M sucrose. In a typical preparation, a yield of 55–65
mg of vesicle protein/100 g of wet tissue was routinely obtained.
Ouabaine-sensitive Na1,K1-ATPase (see below) and cytochrome c
oxidase (19) activities were measured to determine the extent of con-
tamination of SR fraction by sarcolemma and mitochondria.
Preparation of SR Ca21-ATPase Phosphoenzyme andMeasurement of
Its Turnover and Decomposition Rate without and with Acylphos-
phatase—Phosphorylation of SRVs was carried out at 0 °C according to
Beekman et al. (20) with slight modifications. The standard reaction
mixture (total volume 1 ml) contained 30 mM Tris-HCl, pH 7, 1 mM
MgCl2, 120 mM KCl, 125 mM CaCl2 or 3 mM EGTA, and 1 mg of cardiac
SRVs. The reaction was started by the addition of 10 mM[g-32P]ATP (0.2
mCi/mmol), and after 30 s of incubation the reaction was stopped by
adding 4 ml of ice-cold 6% trichloroacetic acid containing 1 mM ATP and
5 mM NaH2P04. The suspension was centrifuged at 30,000 3 g for 10
min, and the supernatant was discarded. Then the pellet was washed
once with the above trichloroacetic mixture and two more times with
0.15 M Tris-HCl, pH 7.4. The final pellet was resuspended in 30 mM
Tris-HCl, pH 7.4, and aliquots were assayed for radioactivity and pro-
tein content. The level of phosphoenzyme was taken as the difference
between the amount of 32P incorporated into vesicles in the presence of
CaCl2 or EGTA. Phosphorylated vesicles (1 mg/ml) were incubated in 30
mM Tris-HCl, pH 7.4, at 37 °C without and with differing amounts of
acylphosphatase. After 30 s, the reaction was stopped with 1 volume of
ice-cold 10% trichloroacetic acid, and the suspension was centrifuged at
13,000 3 g for 5 min. Aliquots of the supernatant were taken to
measure 32P radioactivity. The release of 32P from EP was expressed in
pmol/min, since in preliminary experiments performed with variable
amounts of phosphorylated vesicles we found that it proceeded linearly
over 2 min. In another series of experiments, differing amounts of
phosphorylated vesicles were incubated with a fixed amount of
acylphosphatase (100 units). Controls for spontaneous hydrolysis were
incubated under the same conditions for each concentration of phospho-
rylated vesicles and subtracted to give acylphosphatase-induced phos-
phate release. To estimate the turnover rate of EP, SRVs were phos-
phorylated at 15 °C according to Shigekawa et al. (21) in the absence
and in the presence of varying amounts of acylphosphatase. Reactions
were started by the addition of 20 mM [g-32P]ATP (0.1 mCi/mmol) and
terminated after 30 s by the addition of ice-cold trichloroacetic acid (5%
final concentration) containing 0.1 mM NaH2PO4 and 1 mM ATP. After
centrifugation, aliquots were taken from the supernatant and phos-
phate was determined as in Nassi et al. (22), while the pellets were
treated according the above procedure (21). Both Ca21-dependent
ATPase activity and Ca21-dependent phosphoenzyme level were esti-
mated by subtracting the respective values observed with 1 mM EGTA
from those obtained in the presence of Ca21.
To measure the time course of undenaturated phosphoenzyme de-
composition, SRVs were phosphorylated at 15 °C in the above described
conditions (21). After 30 s, a mixture of 21 mM ADP, 20.9 mMMgCl2, and
145 mM EGTA (25 ml) were added to 0.5 ml of reaction medium, and the
time courses of the phosphoenzyme decomposition were measured.
ATPase Activity Measurements—For Ca21-ATPase, total activity was
assayed in a standard reaction mixture containing 50 mM Tris-HCl, pH
7.4, 3 mMMgCl2, 100 mM KCl, 5 mM NaN3, 50 mM CaCl2, 3 mM ATP, and
50 mg/ml vesicle protein. To determine the basal ATPase activity, the
assays were carried out in presence of 1 mM Tris-EGTA instead of
CaCl2. Reactions were started by the addition of ATP or of an aliquot of
the vesicle suspension and stopped after 10 min with one volume of
ice-cold 20% trichloroacetic acid. After centrifugation (12,000 rpm for 5
min), the amount of Pi released was measured according to Baykov et al.
(23) in aliquots of the supernatant. Ca21-dependent ATPase activity
was estimated by subtracting the basal ATPase activity from the total
Ca21-ATPase and was expressed as nmol/min/mg of SRV protein. Rou-
tinely, in the ATPase assays with 50 mM CaCl2 and no EGTA, a free
Ca21 concentration of approximately 10 mM was calculated using the
equations of Katz et al. (24).
Ouabaine-sensitive Na1,K1-ATPase was assayed in a medium con-
taining 50 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 100 mM NaCl, 5 mM
NaN3, 1 mM Tris-EGTA, 100 mM KCl, 3 mM ATP, and 50 mg/ml vesicle
protein with and without 1 mM ouabain.
Ca21 Influx Measurements into SRVs—For these measurements the
reaction mixture was the same as for ATPase assays except that it
included 45CaCl2 (5 mCi/mmol) and 5 mM oxalate. After 30 s of incuba-
tion at 37 °C, the vesicles were separated from the medium by filtration
through a Millipore filter (0.45-mm pore size), and then the filter was
immediately washed two times with 4 ml of ice-cold 20 mM Tris-HCl, pH
7.4, 1 mM EGTA, and 0.1 M HCl. Oxalate-facilitated 45Ca uptake was
measured as the difference in 45Ca influx into vesicle at zero time and
at the end of incubation (30 s). Radioactivity trapped on the filter was
determined by liquid scintillation spectroscopy.
Treatment of SRVs with cAMP-dependent Protein Kinase (PKA) and
cAMP to Induce Phospholamban Phosphorylation—SRVs (0.5 mg/ml)
were incubated in 40 mM Tris-HCl, pH 7.4, 120 mM KCl, 5 mM MgCl2,
5 mM Tris-ATP with 10 mM cAMP and 1 mg/ml PKA at 25 °C for 10 min.
The reaction was terminated in ice.
Aliquots were taken for assaying Ca21 uptake and Ca21-dependent
ATPase.
In order to evidence the phosphorylation of phospholamban, the
same phosphorylation conditions were used as described above except
that 0.5 mM [g-32P]ATP (10 mCi/mol), 2.5 mM Tris-EGTA, and 25 mM
NaF were present according to Tada et al. (25). The reaction was
stopped by the addition of a solution containing SDS, EDTA, and
b-mercaptoethanol to give final concentrations of 2%, 0.1 mM, and 1%,
respectively. After standing several min on ice, this mixture was incu-
bated for 10 min at 37 °C in order to solubilize the vesicles. A solution
of 20 mM sodium phosphate, pH 7.2, 0.1 mM EDTA, 1% b-mercaptoeth-
anol, 10% glycerol, and 0.005% bromphenol blue was added to the
mixture, and aliquots containing 40 mg of SR protein were applied to an
SDS-15% polyacrylamide gel for electrophoresis according to Laemmli
(26). For autoradiography, the dried gel was exposed to Kodak X-Omat
AR film with an Agfa-Gevaert (Curix MR 800) intensifier screen at
280 °C for 3 days, and the film was then developed.
Data Analysis—Curves were drawn on the basis of the mean values.
The data about EP dephosphorylation were analyzed by means of a
linear regression analysis of observed values plotted in double recipro-
cal form.
The data concerning the dependence of ATP hydrolysis and Ca21
uptake on free Ca21 and ATP concentrations were analyzed using an
equation for a general cooperative model for substrate as follows,
v 5 Vmax@S#N/~KN0.5 1 @S#N! (Eq. 1)
Where Vmax (maximum velocity), K0.5 (concentration required to attain
half-maximal velocity; apparent Km), and N (the equivalent of the Hill
coefficient) were calculated using the Fig.P computer program by Bio-
soft (Cambridge, United Kingdom). Statistical analysis was performed
by Student’s t test or by one way analysis of variance.
RESULTS
Cardiac SRVs used for these studies were examined to de-
termine the possibility that contaminating materials, derived
from other cellular structures, were present in these
preparations.
Sarcolemma and mitochondria contaminations were virtu-
ally absent since ouabain-sensitive Na1,K1-ATPase and cyto-
chrome c oxidase activities were negligible.
Effect of Acylphosphatase on the Phosphorylated Intermedi-
ate of SRVs—SRVs incubated in presence of [g-32P]ATP and
Ca21, as described under “Materials and Methods,” formed a
Ca21-dependent EP, whose level, after subtracting nonspecific
32P bound in presence of EGTA instead of Ca21, was, on aver-
age, 145 pmol of 32P bound/mg of SRV protein, a value that
agrees with that reported by Beekman et al. (20), from whose
method our procedure derives.
To see whether the rate of EP dephosphorylation was af-
fected by acylphosphatase, labeled vesicles were incubated
with different amounts of the enzyme, from 25 to 200 units/mg
of SRV protein. Such ratios were chosen because they are
within the physiological range, which, in heart muscle, was
estimated to be 80–130 units/mg of SRV protein (7). As shown
in Fig. 1, in the presence of acylphosphatase, the release of
phosphate was always higher than spontaneous hydrolysis,
even at the lowest enzyme concentration, and augmented sig-
nificantly with the increase in acylphosphatase/SRV protein
ratio. The maximal effect was observed with 100 units/mg of
SRV protein, at which concentration the phosphate release was
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about 2-fold over spontaneous hydrolysis. No significant en-
hancement of phosphate release was observed using higher
concentrations of the enzyme. On the other hand, heat-dena-
turated acylphosphatase (2 h at 100 °C) added at a concentra-
tion corresponding to 100 units/mg of SRV protein of the active
enzyme did not produce significant modifications of the phos-
phate release with respect to spontaneous dephosphorylation.
To evaluate the affinity of acylphosphatase toward EP, vari-
able amounts of phosphorylated vesicles were incubated with a
fixed amount of our enzyme. Acylphosphatase-induced phos-
phate release rose with increasing EP concentrations, and from
a double reciprocal plot of these data, resulting in a straight
line, an apparent Km of 157.08 6 19.60 nM (mean 6 S.E.) was
calculated (Fig. 2).
Besides these studies, which were conducted using the acid-
denaturated phosphoenzyme, other experiments were per-
formed with the aim of establishing whether acylphosphatase
affected the turnover rate of phosphoenzyme intermediate and
had a different effect on the two EP forms, namely the ADP-
sensitive (E1P) and the ADP-insensitive (E2P) form. According
to Shigekawa and Akowitz (21), the rate of EP turnover was
determined as the ratio between the rate of ATP hydrolysis and
the phosphoenzyme levels, both being measured at the steady
state, which, under our conditions, was reached within 30 s
after the start of the phosphorylation reaction. As shown in Fig.
3, when these measurements were taken in the presence of
differing acylphosphatase amounts, the ratio increased with
acylphosphatase concentrations, reaching a value that, with
100 units/mg of SRV protein, was about 2-fold greater than
that in the absence of added enzyme. To explore the possibility
of a different effect of acylphosphatase on E1P and E2P, we
measured the time course of the phosphoenzyme decomposition
after the steady state was reached and further phosphorylation
was prevented by adding an excess of EGTA and MgADP. In
agreement with previous reports (21) we found that phosphoen-
zyme decomposition exhibited an initial rapid phase without a
FIG. 1. Effect of different acylphosphatase concentrations on
SR Ca21-ATPase phosphoenzyme intermediate. Labeled vesicles
(1 mg) were incubated in 1 ml of 30 mM Tris-HCl, pH 7.4, at 37 °C
without and with differing amounts of acylphosphatase. The phos-
phoenzyme level was 145 pmol of 32P bound/mg of SRV protein. The
initial rate of phosphate release was measured as described under
“Materials and Methods” and was expressed as pmol/min. Each point is
the mean 6 S.E. of five experiments performed on differing vesicle
preparations. All the changes in phosphate release induced by active
acylphosphatase were statistically significant (p , 0.01 by the one-way
analysis of variance). Heat-denaturated acylphosphatase (2 h at 100 °C)
(l) was added at a concentration corresponding to 100 units of active
enzyme/mg of SRV protein.
FIG. 2. Initial rate of acylphosphatase-induced dephosphoryl-
ation of cardiac SR Ca21 ATPase phosphoenzyme as a function
of EP concentration. 100 units of acylphosphatase were incubated in
30 mM Tris-HCl, pH 7.4, at 37 °C with differing amounts of labeled
vesicles. EP concentration [EP] was expressed as pmol of 32P bound per
ml. The initial rate of dephosphorylation (V), net for spontaneous hy-
drolysis, was expressed as pmol of 32P released per min/ml. Each point
represents the mean value of five determinations. Data are shown as a
double reciprocal plot.
FIG. 3. Acylphosphatase dependence of the ratio between the
rate of ATP hydrolysis (V) and Ca21-ATPase EP level. The rates of
ATP hydrolysis and the Ca21-ATPase phosphoenzyme level were meas-
ured at 15 °C in a medium containing 0.25 mg/ml SRV protein, 15 mM
imidazole-HCl (pH 7), 2 mMMgCl2, 20 mM [g-
32P]ATP, and 20 mM CaCl2.
Each point represents the mean value 6 S.E. of five determinations.
Changes observed with increasing amounts of acylphosphatase were
statistically significant (p , 0.01 by the one way analysis of variance).
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corresponding Pi liberation, followed by a slow phase, where
the amount of Pi liberated corresponded to the decrease in EP
level. The rapid phase is ascribed to the decomposition of the
ADP-sensitive form of phosphoenzyme that reacts with added
ADP to form ATP, whereas the slow late phase represents the
hydrolysis of the ADP-insensitive phosphoenzyme that does
not donate its phosphate group to ADP. As it is apparent in Fig.
4, in the presence of acylphosphatase (100 units/mg of SRV
protein) the rate of the slow phase of EP decomposition was
markedly increased when the rate of the rapid phase was
slightly affected, which suggests a preferential action of our en-
zyme toward the ADP-insensitive form (E2P) of phosphoenzyme.
Effect of Acylphosphatase on the Ca21-ATPase Activity and
Ca21 Uptake of SRVs—The rate of Ca21-dependent ATP hy-
drolysis by SRVs was measured at the free Ca21 concentration
of 10 mM, which, in agreement with other authors (27–29), we
found to represent the optimal concentration for the Ca21-de-
pendent ATP hydrolysis. As stated above, mitochondrial con-
tamination was negligible in our SRV preparations; however,
sodium azide was present in all assays to inhibit the activity of
mitochondrial Ca21-ATPase, eventually present as a minor
contaminant (6). This ensured that the measured Ca21-ATPase
activity was only due to SRVs. In order to compare the effects
on ATP hydrolysis and on Ca21 transport all these determina-
tions were performed in the same experimental conditions ex-
cept that in Ca21 uptake assays oxalate was added in order to
enhance the amount of transported Ca21 into the vesicles, since
ATPase activity was not affected by this compound (3). Thus,
oxalate-facilitated Ca21 uptake was measured and expressed
as nmol of Ca21 transported/min/mg of SRV protein. A 30-s
incubation was performed in Ca21 transport experiments after
we found that Ca21 influx measured at 30-s intervals pro-
ceeded linearly over a 2 min period. As shown in Fig. 5, in the
presence of increasing amounts of acylphosphatase the rates of
Ca21-dependent ATP hydrolysis and of Ca21 uptake were sig-
nificantly stimulated. Moreover, with all the used enzyme
concentrations, the enhancements of the two processes were
quantitatively similar; with 100 units/SRV protein, the concen-
tration that in the present study gave the maximal effect on the
phosphate release from EP, both Ca21-ATPase activity and
Ca21 uptake were almost doubled with respect to the values
observed without added acylphosphatase. No significant effect
on these processes was observed using heat-denaturated
acylphosphatase.
We also studied the effect of acylphosphatase on the rate of
ATP hydrolysis and of Ca21 uptake as a function of free Ca21
and ATP concentrations. Since a positive cooperativity was
described in the Ca21 dependence of calcium transport into SR,
due to the presence of two Ca21 binding sites in the Ca21 pump
(30), these data were analyzed using the Michaelis-type equa-
tion reported under “Materials and Methods,” which is suitable
for both cooperative and noncooperative (n 5 1) behaviors. As
illustrated in Fig. 6, acylphosphatase markedly increased ATP
hydrolysis at all used free Ca21 and ATP levels. Without the
enzyme the calculated concentrations required for half-maxi-
mal ATPase activity (apparent Km values) were 1.40 6 0.21 mM
for Ca21 and 0.26 6 0.04 mM for ATP, both findings in accord-
ance with previous reports (28, 31). With acylphosphatase
these values were significantly lower, notably 0.36 6 0.06 mM
for Ca21 and 0.16 6 0.02 mM for ATP. Both in the absence and
in the presence of acylphosphatase, the calculated N values for
the rate of ATP hydrolysis as a function of free Ca21 and ATP
concentrations were near 1, indicating the lack of positive
cooperative effects.
As for the dependence of Ca21 uptake on the free Ca21
concentration (Fig. 7), in the absence of acylphosphatase an
apparent Km of 1.77 6 0.23 mM and an N value of 1.42 6 0.20
were calculated; when the enzyme was added, also in this case
FIG. 4. Time course of decomposition of cardiac Ca21-ATPase
EP after the addition of 21 mM ADP, 20.9 mM MgCl2, and 145 mM
EGTA with (l) and without (E) acylphosphatase (100 units/mg
of SRV protein). SRVs were phosphorylated as described under “Ma-
terials and Methods.” At 30 s (2), 25 ml of a mixture of 21 mM ADP, 20.9
mM MgCl2 and 145 mM EGTA were added to 0.5 ml of reaction
medium, and the time courses of the phosphoenzyme decomposition
were measured. Each point represents the mean value 6 S.E. of five
determinations.
FIG. 5. Effect of different acylphosphatase concentrations on
Ca21 ATPase activity and Ca21 uptake of cardiac SRVs. Ca21
ATPase activity (E) and Ca21 uptake (l) were assayed as described
under “Materials and Methods.” Ca21-ATPase activity was expressed
as nmol of ATP split per min/mg of SRV protein and Ca21 uptake as
nmol of Ca21 transported into vesicles per min/mg of SRV protein. Each
point represents the mean value 6 S.E. of five determinations. Changes
observed in Ca21-ATPase activity and Ca21 transport, with increasing
amounts of acylphosphatase, were statistically significant (p , 0.01 by
the one way analysis of variance). M and f, respectively, indicate the
values obtained for Ca21 ATPase activity and Ca21 uptake with an
amount of heat-denaturated acylphosphatase corresponding to 100
units of the active enzyme.
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at 100 units/mg of SRV protein, an increase in the rate of Ca21
transport was observed at all the used free Ca21 concentra-
tions, and the apparent Km value was significantly lowered to
1.21 6 0.08 mM, while the value of N was not significantly
changed.
Autoradiogram of SRVs Phosphorylated by PKA and cAMP—
SRVs were phosphorylated with [g-32P]ATP in the presence of
PKA and cAMP as described under “Materials and Methods.”
Fig. 8 shows the autoradiography of 32P-phosphorylated SRVs
subjected to electrophoresis. Phosphorylation performed in the
presence of PKA and cAMP resulted in a band at about 26–28
kDa corresponding to the phosphorylated phospholamban and
another one at 9–11 kDa, probably a low molecular mass form
of this protein (32). It is also evident that a band at about 54–56
kDa likely derived from autophosphorylation of protein kinase
occurring at the catalytic subunit as reported by other authors
(25). These bands were not present when SRVs were phospho-
rylated in the absence of PKA and cAMP.
Effect of Acylphosphatase on the Ca21-ATPase Activity and
on the Ca21 Uptake in SRVs Phosphorylated by PKA and
cAMP—For these studies SRVs were treated as described un-
der “Materials and Methods.” Phosphorylated SRVs showed, as
previously reported (3, 6, 30, 33, 34), a marked stimulation of
Ca21-dependent ATPase activity and Ca21 uptake. When we
measured the rate of ATP hydrolysis as a function of the free
Ca21 and ATP concentrations (Fig. 9), we found that in the
phosphorylated SRVs the calculated apparent Km values were
FIG. 6. Cardiac SR Ca21 ATPase activity as a function of free
Ca21 (A) and ATP (B) concentrations. SRVs (50 mg/ml) were as-
sayed in the absence (E) and in the presence (l) of 100 units of
acylphosphatase. Each point represents the mean value 6 S.E. of five
determinations.
FIG. 7. Cardiac SR Ca21 uptake as a function of free Ca21
concentration. SRVs (50 mg/ml) were assayed in the absence (E) and
in the presence (l) of 100 units of acylphosphatase. Each point repre-
sents the mean value 6 S.E. of five determinations.
FIG. 8. Autoradiogram of PKA-phosphorylated SRVs. SRVs
were phosphorylated as described under “Materials and Methods” in
the absence (lane 1) and in the presence (lane 2) of PKA and cAMP.
Molecular mass markers are shown on left.
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0.69 6 0.09 mM for Ca21 and 0.11 6 0.02 mM for ATP, both
values significantly lower than those observed in unphospho-
rylated vesicles (p , 0.01). As for the kinetics of Ca21 transport
(Fig. 10), phosphorylation resulted, as expected, in a reduction
of the free Ca21 concentration required for half-maximal Ca21
uptake (1.17 6 0.08 mM versus 1.77 6 0.23 mM); in this connec-
tion, in contrast with previous reports (30) but in agreement
with Movsesian (35), we did not find significant changes in the
positive cooperativity for Ca21 according to whether phospho-
lamban was in its dephospho- or phospho-form. When
acylphosphatase was added to the phosphorylated SRVs, al-
ways at the optimal concentration of 100 units/mg of SRV
protein, the rates of both ATP hydrolysis and Ca21 transport
were further and significantly augmented, but the stimulatory
effects of our enzyme were less striking (only about 20% over
the control values) than those observed using unphosphoryl-
ated vesicles. Also the changes induced by acylphosphatase in
the apparent Km values for Ca
21 and ATP, both for ATPase
activity and Ca21 uptake, were less marked in the phosphoryl-
ated vesicles.
Table I summarizes all the observed acylphosphatase effects
on the kinetic parameters of the Ca21 pump ATPase in phos-
phorylated and unphosphorylated heart SRVs.
DISCUSSION
The findings here reported indicate that acylphosphatase
can actively hydrolyze the phosphoenzyme intermediate of the
cardiac SR Ca21 pump. Such result was expected, given the
acylphosphate nature of the phosphoenzyme, the catalytic
properties of acylphosphatase, and our previous findings indi-
cating a similar effect of our enzyme on the EP intermediates of
other Ca21-ATPase. However, we think that two features of
acylphosphatase action emerging from the present study are of
interest: one is that the hydrolysis of EP occurred to a signifi-
cant extent even using an enzyme amount corresponding to the
lower limit of the physiological content in heart muscle; the
other is represented by the low Km value (on the order of 10
27
M) that we found for EP hydrolysis, which suggests a distinctly
high affinity in our enzyme toward this particular substrate,
since the Km values for other potential substrates, such as the
soluble low molecular weight compounds mentioned in the
Introduction, are always higher than 1024 M.
When added to intact SRVs, used as a source of the Ca21
pump as it exists in situ, acylphosphatase affected the func-
tional properties of this active transport system, notably the
kinetics of ATP hydrolysis and of Ca21 transport. In order to
compare the effects on the two processes all the experiments
were performed under the same conditions of temperature, pH,
and Ca21 and ATP concentrations. Acylphosphatase addition,
at the same concentrations used to study the effects on EP,
resulted in a stimulation of the rate of ATP hydrolysis that
FIG. 9. Ca21 ATPase activity of PKA-phosphorylated SRVs as a
function of free Ca21 (A) and ATP (B) concentrations. SRVs were
phosphorylated as described under “Materials and Methods,” and ali-
quots were taken and assayed for Ca21 ATPase activity in the standard
reaction medium in the absence (E) and in the presence (l) of 100 units
of acylphosphatase. Each point represents the mean value 6 S.E. of five
determinations.
FIG. 10. Ca21 uptake of PKA phosphorylated SRVs as a func-
tion of free Ca21 concentration. SRVs were phosphorylated as de-
scribed under “Materials and Methods,” and aliquots were taken and
assayed for Ca21 uptake in the standard reaction medium in the ab-
sence (E) and in the presence (l) of 100 units of acylphosphatase. Each
point represents the mean value 6 S.E. of five determinations.
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matched a parallel enhancement of ATP-dependent Ca21 in-
flux into SRVs. Thus, although the effects were more marked
with increasing acylphosphatase concentrations, no remarka-
ble changes were observed in the stoichiometric Ca21/ATP
ratio, which, in agreement with several previous reports (37,
38) was always near the value of 1 mol of Ca21 transported per
mol of ATP hydrolyzed. Apropos of these results, it should be
noted that acylphosphatase does not exhibit per se hydrolytic
activity on ATP, nor did its addition induce changes in the
ATP-independent Ca21 influx into SRVs (data not shown);
thus, the increase in the rate of ATP hydrolysis may only be
ascribed to a stimulation of the Ca21 pump ATPase activity,
while the enhancement of Ca21 transport is not the result of a
change in the passive permeability of SR membrane to this
cation. It is also noteworthy that heat-denaturated acylphos-
phatase (2 h at 100 °C), which did not affect the phosphate
release from EP, also did not modify ATPase and Ca21 pump-
ing activities, indicating that all the observed acylphosphatase
effects require the enzyme in a catalytically active form and/or
in its native conformation. This also suggests a connection
between the acylphosphatase effects on EP hydrolysis and on
the functional properties of cardiac SR pump, all the more so
that, in both cases, the modifications induced by acylphos-
phatase were of the same sign (stimulatory) and of the same
order of magnitude.
As an interpretation of the data here reported, we propose
that all the observed acylphosphatase effects are the results of
an accelerated EP turnover, which, however, would not alter
the normal ordered sequence of reactions and conformational
transitions associated with Ca21 transport. In other words,
acylphosphatase-induced hydrolysis of EP, in competition with
its own hydrolytic catalysis, would take place on the E2P form,
that is at step V of the reaction system here proposed and
derived from that reported by Tada et al. (3) (Fig. 11). Since
E2P hydrolysis is considered to be the rate-limiting step of the
entire process (21), this would result in a more rapid pumping
cycle and, at the same time, could favor a shift of the equilib-
rium between the two proposed conformationally distinctive
forms of the Ca21 pump, E1 and E2, toward E1, characterized
by higher affinity for Ca21 and ATP. The results of the present
study provide direct and indirect evidence in support of this
interpretation. Direct evidence consists of the increased EP
turnover rate that we observed in the presence of increasing
acylphosphatase concentrations and in the finding that the
hydrolytic effect of our enzyme was much more marked toward
the ADP-insensitive form (E2P) than toward the ADP-sensitive
form (E1P) of the phosphoenzyme intermediate. Indirect evi-
dence comes from the observations that the effects of PKA
phospholamban phosphorylation on the measured kinetic prop-
erties of heart SR Ca21 pump were qualitatively and quanti-
tatively similar to those induced by acylphosphatase. Since
from the extensive studies of Tada et al. (3) phospholamban
phosphorylation appears to cause the above effects enhancing
both formation and decomposition of EP (39), it may be reason-
able to suppose that acylphosphatase, in spite of a different
kind of action, does affect in a similar way the function of the
Ca21 pump.
As for the reduction in the stimulatory effect of acylphos-
phatase on SR Ca21 pump upon phospholamban phosphoryla-
tion, it is difficult to explain this finding on the grounds of the
data still now available. However, since it is generally accepted
that unphosphorylated phospholamban inhibits the Ca21
pump while phospholamban phosphorylation results in a relief
of this inhibitory effect (40) we suggest as a tentative hypoth-
esis that in the unphosphorylated SRVs acylphosphatase, in
addition to the stimulatory effect due to its catalytic activity,
could also act through another mechanism consisting of the
removal of phospholamban inhibition. In fact, the basic char-
acter of acylphosphatase might favor the interaction of this
enzyme protein with the Ca21 pump, which exhibits affinity for
polycationic compounds (37). Furthermore, studies from our
laboratory (41) on the tridimensional structure of muscle
acylphosphatase have shown that this protein contains a struc-
tural motif where 12 residues (from position 55 to 66) may be
proposed to form an amphipatic a-helical structure with a
prevalence of basic groups, a structure resembling that of the
phospholamban cytoplasmic 1A domain (42), which appears to
be essential for the association of phospholamban with the SR
Ca21 pump. Given this structural analogy, acylphosphatase
might be supposed to interact with SR Ca21 pump, taking the
place of unphosphorylated phospholamban, whose inhibitory
effect would therefore be removed. However, phospholamban
does not appear to be strictly necessary for acylphosphatase
action, since we found (data not shown) that this enzyme had a
stimulatory effect on Ca21-ATPase activity and on Ca21 trans-
port also in SRVs from fast twitch skeletal muscle (rabbit
adductor magnus), which lacks phospholamban. In any case,
more conclusive proofs to establish if the acylphosphatase ef-
fect on cardiac SR Ca21 pump is due, at least in part, to a
displacement of phospholamban will arise from studies in pro-
FIG. 11. A scheme of Ca21 pump ATPase. The scheme is based on
that reported by Tada et al. (3). E1 and E2 represent two different forms
of the enzyme, which exhibit higher and lower affinities for Ca21,
respectively; i and o indicate the inside and outside of SR membranes.
E1P is the form of the phosphorylated intermediate having higher
affinity for Ca21, while E2P has a lower affinity for Ca
21.
TABLE I
Effect of acylphosphatase on Ca21-ATPase activity and Ca21 uptake in unphosphorylated and in PKA-phosphorylated cardiac SRVs
Unphosphorylated SRVs Phosphorylated SRVs
Ca21-ATPase Ca21 Ca21-ATPase Ca21
Activity KmCa
21 Km ATP Uptake KmCa
21 Activity KmCa
21 Km ATP Uptake KmCa
21
nmol/mg/min mM mM nmol/mg/min mM nmol/mg/min mM mM nmol/mg/min mM
Control 109.04 6 5.03 1.40 6 0.21 0.26 6 0.04 105.05 6 2.31 1.77 6 0.23 296.20 6 8.94 0.69 6 0.09 0.11 6 0.02 163.60 6 6.62 1.17 6 0.08
ACPase 208.70 6 4.57a 0.36 6 0.06b 0.16 6 0.02b 174.60 6 5.81a 1.21 6 0.08b 346.10 6 9.35a 0.31 6 0.03b 0.08 6 0.01c 192.80 6 6.88a 1.14 6 0.08c
a p , 0.02 when compared with control values using Student’s t test (n 5 5).
b p , 0.05 when compared with control values using Student’s t test (n 5 7).
c Not significant.
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gress in our laboratory; planned experiments involve the use of
purified heart SR Ca21-ATPase (SERCA 2) and of a negative
dominant of acylphosphatase, obtained by site-directed mu-
tagenesis (43), which is virtually devoid of catalytic activity but
retains the structural motif supposed to interact with the Ca21
pump instead of phospholamban.
In conclusion, the results of the present study indicate that
acylphosphatase, in its catalytically active form, can interfere
with the action mechanism of heart SR Ca21-ATPase, at the
same time affecting the functional properties of this active
transport system. To our knowledge, this represents the first
report concerning changes in the activity of heart SR Ca21
pump by a cytosolic enzyme normally present in the same
tissue. Certainly, at present we are not able to ascribe a phys-
iological significance to these findings; however from some
features of acylphosphatase action (notably its high affinity for
EP and its ability to act even at low concentrations) such a
hypothesis should be considered, in our opinion, something
more than mere speculation. In any case, further studies about
the details of acylphosphatase action and the molecular basis of
its interaction with SR membrane would be of interest to as-
certain if this enzyme may be involved in vivo, in addition to
the other mechanisms now recognized, in the regulation of SR
Ca21 pump activity, hence in the control of calcium homeosta-
sis in heart muscle.
Acknowledgment—We are grateful to Dr. Giovanni Rizzuti for
assistance.
REFERENCES
1. Caroni, P. and Carafoli, E. (1983) Eur. J. Biochem. 132, 451–460
2. Inesi G. (1985) Annu. Rev. Physiol. 47, 573–601
3. Tada, M., Kadoma, M., Inui, M., and Fujii, J-I. (1988) Methods Enzymol. 157,
107–154
4. Martonosi, A. (1969) J. Biol. Chem. 244, 613–620
5. Bastide, F., Meissner, G., Fleischer, S., and Post, R. L. (1973) J. Biol. Chem.
248, 8485–8391
6. Tada, M., Kirchberger, A., Repke, D. I., and Katz, A. M. (1974) J. Biol. Chem.
249, 6174–6180
7. Berti, A., Degl’Innocenti, D., Stefani, M., Liguri, G., and Ramponi, G. (1987)
Ital. J. Biochem 36, 82–91
8. Ramponi, G., Treves, C., and Guerritore, A. (1967) Experientia (Basel) 23, 1019
9. Ramponi, G., Melani, F., and Guerritore, A. (1961) G. Biochim. 10, 189–196
10. Berti, A., Stefani, M., Liguri, G., Camici, G., Manao, G., and Ramponi, G.
(1977) Ital. J. Biochem. 26, 377–378
11. Nassi, P., Nediani, C., Liguri, G., Taddei, N., and Ramponi, G. (1991) J. Biol.
Chem. 266, 10867–10871
12. Nediani, C., Marchetti, E., Liguri, G., and Nassi, P. (1992) Biochem. Int. 26,
715–723
13. Ramponi, G., Guerritore, A., Treves, C., Nassi, P., and Baccari, V. (1969) Arch.
Biochem Biophys.130, 362–369
14. Stefani, M., Camici, G., Manao, G., Cappugi, G., Liguri, G., Degl’ Innocenti, D.,
Landi, N., and Berti, A. (1985) Ital. J. Biochem. 34, 94–108
15. Ramponi, G., Treves, C., and Guerritore, A. (1966) Experientia (Basel) 22, 705
16. Camici, G., Manao, G., Cappugi, G., and Ramponi, G. (1976) Experientia
(Basel) 32, 535–536
17. Beisenherz, G., Boltze, H. G., Bu¨cher, T. H., Czock, R., Garbade, K. H.,
Meyer-Arendt, E., and Pfliderer, G. (1953) Z. Naturforsch. 8b, 555–577
18. Jones, L. R., Besch, H. R., Jr., Fleming, J. W., McConnaughey, M. M., and
Watanabe, A. M. (1979) J. Biol. Chem. 254, 530–539
19. Remacle, J. A., Houbion, A., and Houben, A. (1980) Biochim. Biophys. Acta
630, 57–70
20. Beekman, R. E., van Hardeveld, C., and Simonides, W. S. (1989) Biochem. J.
259, 229–236
21. Shigekawa, M., and Akowitz, A. A. (1979) J. Biol. Chem. 254, 4726–4730
22. Nassi, P., Marchetti, E., Nediani, C., Liguri, G., and Ramponi, G. (1993)
Biochim. Biophys. Acta 1147, 19–26
23. Baykov, A. A., Evtushenko, O. A., and Avaeva, S. M. (1988) Anal. Biochem.
171, 266–270
24. Katz, A. M., Repke, D. I., Upshaw, J. E., and Polascik, M. A. (1970) Biochim.
Biophys. Acta 205, 473–490
25. Tada, M., Kirchberger, M. A., and Katz, A. M. (1975) J. Biol. Chem. 250,
2640–2647
26. Laemmli, U. K. (1970) Nature 227, 680–685
27. Wuytack, F., De Schutter, G., and Casteels, R. (1980) Biochem. J. 190,
827–831
28. Shigekawa, M., Finegan, J. M., and Katz, A. M. (1976) J. Biol. Chem. 251,
6894–6900
29. Gupta, R. C., Davis, B. A., and Kranias, E. G. (1988)Membr. Biochem. 7, 73–86
30. Hicks, M. J., Shigekawa, M., and Katz, A. M. (1979) Circ. Res. 44, 384–391
31. Sasaki, T., Inui, M., Kimura, Y., Kuzuya, T., and Tada, M. (1992) J. Biol.
Chem. 267, 1674–1679
32. Plank, B., Wyskovsky, W., Hellman, G., and Suko, J. (1983) Biochim. Biophys.
Acta 732, 99–109
33. Kirchberger, M. A., Tada, M., and Katz, A. M. (1974) J. Biol. Chem. 249,
6166–6173
34. Tada, M., Ohmori, F., Yamada, M., and Abe, H. (1979) J. Biol. Chem. 254,
319–326
35. Movsesian, M. A. (1992) Basic Res. Cardiol. 87, 92–102
36. Deleted in proof
37. Xu, Z-C., and Kirchberger, A. M. (1989) J. Biol. Chem. 264, 16644–16651
38. Chamberlain, B. K., Levitsky, D. O., and Fleischer, S. (1983) J. Biol. Chem.
258, 6602–6609
39. Tada, M., and Katz, A. M. (1982) Ann. Rev. Physiol. 44, 401–442
40. Lu, Y-Z., Xu, Z-C., and Kirchberger, A. M. (1993) Biochemistry 32, 3105–3111
41. Pastore, A., Saudek, V., Ramponi, G., and Williams, R. J. P (1992) J. Mol. Biol.
224, 427–440
42. Toyofuku, T., Kurzydlowsky, K., Tada, M., and MacLennan, D. H. (1994)
J. Biol. Chem. 269, 3088–3094
43. Taddei, N., Stefani, M., Magherini, F., Chiti, F., Modesti, A., Raugei, G., and
Ramponi, G. (1996) Biochemistry 35, 7077–7083
Acylphosphatase Modulation of Cardiac SR Calcium Pump 19073
 at UNIV DEG
LI STUDI DI FIREN, on O
ctober 10, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
